Precision Motion Health

Precision Motion Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

Precision Motion Health is a commercial-stage diagnostics and data intelligence company focused on musculoskeletal health. Its core technology is an FDA-registered Electromyographic Functional Assessment (EFA) system, which it has evolved into a broader AI-powered platform for injury risk prediction, objective assessment, and personalized recovery. Founded in 2012 (originally as Emerge Diagnostics) and rebranded in 2024, PMH reports validated outcomes for large employers, including significant reductions in claim costs and duration, positioning it at the intersection of digital health, diagnostics, and occupational medicine.

Musculoskeletal DisordersOccupational Health

Technology Platform

The Soft Tissue Intelligence Platform integrates a patented, FDA-registered Electromyographic Functional Assessment (EFA) – which combines surface EMG, range-of-motion, and force measurement – with AI and machine learning analytics. This platform transforms objective diagnostic data into predictive risk insights and personalized recovery pathways.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The massive and growing cost of musculoskeletal disorders in workers' compensation and general health presents a substantial addressable market.
Expansion into adjacent verticals like corporate wellness and sports medicine offers significant growth potential by applying the same core technology for prevention and performance.
The shift towards value-based care and remote monitoring accelerates demand for objective, data-driven solutions like PMH's platform.

Risk Factors

Market adoption relies on continuously proving return-on-investment to cost-conscious employers and insurers in a competitive landscape.
The clinical validation and reimbursement pathways for the AI and predictive components of the platform are less established than for the core diagnostic.
Successful expansion beyond the core workers' comp market requires different sales strategies and product adaptations, presenting execution risk.

Competitive Landscape

PMH competes in a fragmented market including traditional diagnostic imaging, wearable sensor companies (e.g., dorsaVi, VALD), digital musculoskeletal therapy platforms (e.g., Hinge Health, Sword Health), and broader workplace safety analytics firms. Its key differentiation is the combination of an FDA-registered diagnostic device with AI analytics, targeting the specific workflow and cost-containment needs of the workers' compensation ecosystem.